Skip To Main Content
Bartha M. Knoppers on Muck Rack

Bartha M. Knoppers

As seen in: Nature, Yahoo Canada, SAGE Publishing, The Conversation, The Globe and Mail, The Toronto Star, The New England Journal of Medicine, Science Magazine, Medical Xpress, Cell Press and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Bartha M.

Contact Bartha M., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

When to return genomic newborn screening results: health care professional perspectives

|
By Adam Buchanan, Aaron J Goldenberg, Bartha M. Knoppers
| medRxiv
Dr Green receives compensation for advising Allelica, Mammoth Biosciences, and Genomic Life, and is a co-founder of Genome Medical and Nurture Genomics. The other authors have no conflicts of interest relevant to this article to disclose. I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Open in Who Shared View Duplicates (84) Issue with article?

Genomic newborn screening: a scoping review of the field’s evolution and associated ethical, legal, and social implications

|
By Gemma Brown, Loren Walker, Mutiat Afolabi, Paul Bain, Ana Eliza Bonilha, Bimal P. Chaudhari, John Christodoulou, Ziyi Dai, Jan M Friedman, Amy Gaviglio, Robert Green, Subhashini Jagu, Bartha M. Knoppers, Zornitza Stark, Danya Vears, Yvonne Bombard, Anna Lewis, Aliza Wilson
| Nature Verified
Abstract The integration of genomic sequencing into newborn screening (genomic newborn screening; gNBS) has the potential to identify more presymptomatic babies who could benefit from early intervention compared to traditional universal newborn screening (NBS). Realizing these benefits requires careful navigation of ethical, legal, and social implications (ELSI) to minimize harms, promote equity, and maintain trust in NBS programs.
Open in Who Shared Issue with article?

Genomic newborn screening: data retention for research and clinical reuse

|
By Anna Lewis, Aaron J Goldenberg, Bartha M. Knoppers
| Nature Verified
Abstract The integration of genomic sequencing into public health newborn screening (NBS), gNBS, could identify far more children that would meet screening guidelines than existing biochemical NBS. The retention of genomic data from gNBS could have huge benefits for research and could also enable potential clinical reuse.
Open in Who Shared Issue with article?
See all 37 articles